BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23285933)

  • 1. [Systematic analysis on clinical safety of Shuxuetong injection].
    Guo XF; Wen ZH; Xie YM; Liu SN; Li ZY; Chen DC
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2782-5. PubMed ID: 23285933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events to Houttuynia injection: A systematic review.
    Wang L; Cui X; Cheng L; Yuan Q; Li T; Li Y; Deng S; Shang H; Bian Z
    J Evid Based Med; 2010 Aug; 3(3):168-76. PubMed ID: 21349062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Building safety evidence body of shuxuetong injection].
    Jiang JJ; Liao X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3630-2. PubMed ID: 25532409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis and countermeasures of adverse drug reactions of traditional Chinese medicine injections in children].
    Zhang XL; Li M; Rong P; Ma R
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2807-9. PubMed ID: 23285940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
    Ai QH; Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions of Shuanghuanglian injection: a systematic review of public literatures.
    Wang L; Cheng L; Yuan Q; Cui X; Shang H; Zhang B; Li Y
    J Evid Based Med; 2010 Feb; 3(1):18-26. PubMed ID: 21349036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of drug safety information using large-scale adverse drug reactions database].
    Morikawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apply association rules to analysis adverse drug reactions of shuxuening injection based on spontaneous reporting system data].
    Yang W; Xie YM; Xiang YY
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3616-20. PubMed ID: 25532406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reevaluation on adverse reaction monitoring and safety of proprietary Chinese medicines of Chongqing from 2005 to 2011].
    Yang YY; Dong Z; Zhu SB; Sun HF; Yang MP
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3659-63. PubMed ID: 23477159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].
    Wei X; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2748-51. PubMed ID: 23285926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of 103 cases with adverse drug reactions induced by sanqizongzaogan injection].
    Chen Y; Li Y; Zhu G
    Zhongguo Zhong Yao Za Zhi; 2010 Jan; 35(2):237-9. PubMed ID: 20394303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
    Li C; Xu T; Zhou P; Zhang J; Guan G; Zhang H; Ling X; Li W; Meng F; Liu G; Lv L; Yuan J; Li X; Zhu M
    BMC Complement Altern Med; 2018 Oct; 18(1):277. PubMed ID: 30326892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Literature review report on safety evaluation about Kudiezi injection].
    Liao X; Shen H; Xie YM; Zhang W; Yang W; Lv ZG
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2786-8. PubMed ID: 23285934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spontaneous reportintg system data based on shuxuetong injection adverse reactions signal warning analysis].
    Jiang JJ; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2994-7. PubMed ID: 24471318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Literature analysis of tumor treatment by Shenmai injection].
    Wang LX; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2804-6. PubMed ID: 23285939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.